background
background
LNTH
Lantheus Holdings
$59.21
+0.05
+0.08%
Earnings Expectation?
Beat
Meet
Miss
Expected Price Action?
Up
Flat
Down

Lantheus Beat Expectations

Wednesday, August 6, 2025 at 7:00 AM ET

Lantheus (LNTH) reported earnings of $1.77 per share on revenue of $378.05 million for the second quarter ended June 2025. The consensus earnings estimate was $1.88 per share on revenue of $388.72 million. The Earnings Whisper number was $1.62 per share. The company beat expectations by 9.26% while revenue fell 4.07% compared to the same quarter a year ago.

The company said it expects 2025 earnings of $5.50 to $5.70 per share on revenue of $1.475 billion to $1.510 billion. The company's previous guidance was earnings of $6.60 to $6.70 per share on revenue of $1.550 billion to $1.585 billion, and the current consensus earnings estimate is $5.72 per share on revenue of $1.57 billion for the year ending December 31, 2025.

Lantheus Holdings, Inc. is the parent company of Lantheus Medical Imaging, Inc., Progenics Pharmaceuticals, Inc. and EXINI Diagnostics AB and an established leader and fully integrated provider of innovative imaging diagnostics, targeted therapeutics and artificial intelligence solutions to Find Fight and Follow® serious medical conditions.

Earnings Whisper Grade
Earnings Whisper GradeEarningsWhisper®edarG-
Power Rating
-
Reported Earnings
$1.77
Earnings Whisper®
$1.62
Consensus Estimate
$1.88
Earnings Surprise
9.3%
Earnings Growth
0.6%
Reported Revenue
$378.05 Mil
Revenue Estimate
$388.72 Mil
Revenue Surprise
-2.7%
Revenue Growth
-4.1%